Approximately 94% of SMA patients carry a homozygous exon 7 deletion of the Survival Motor Neuron 1 gene (SMN1), that abrogates expression of the SMN protein1,2. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.